Potential coeliac disease in children: a single-center experience.

IF 3.8 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY
Luisa Lonoce, Simona Ferraro, Luca Lalli, Luisa Abbattista, Chiara Hruby, Cristina Cocuccio, Cecilia Mantegazza, Elena Groppali, Fabio Pasotti, Francesca Severino, Gianvincenzo Zuccotti, Elena Pozzi
{"title":"Potential coeliac disease in children: a single-center experience.","authors":"Luisa Lonoce, Simona Ferraro, Luca Lalli, Luisa Abbattista, Chiara Hruby, Cristina Cocuccio, Cecilia Mantegazza, Elena Groppali, Fabio Pasotti, Francesca Severino, Gianvincenzo Zuccotti, Elena Pozzi","doi":"10.1515/cclm-2025-0098","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Potential coeliac disease (PCD) is defined by the presence of positive CD-specific autoantibodies with a normal/extremely mildly damaged intestinal mucosa. This study sought to examine the progression of PCD in children maintaining a gluten-containing diet and to identify risk factors associated with the onset of CD. A comparative literature review was conducted to assess the results in the context of existing evidence.</p><p><strong>Methods: </strong>A retrospective cohort study was performed on 67 children diagnosed with PCD between January 2005 and January 2022, with a maximum follow up of 53 months. The associations between baseline clinical characteristics and the development of CD were assessed using hazard ratios (HR).</p><p><strong>Results: </strong>Nineteen percent (19 %) (12/67, cumulative incidence) of PCD children, with a median age of 4.3 years, progressed to CD during a median follow up period of 30 months. A fluctuating trend in tissue transglutaminase IgA (tTG-IgA) levels was observed in 35.8 % (24/67) of the children, while 46.2 % (31/67) showed tTG-IgA negativization. In univariable analysis, the presence of autoimmune disease and one-year increase in age at diagnosis were significantly associated with CD progression [HR=17.7 (95%CI: 3.0-106.8; p=0.0017) and HR=1.3 (95%CI: 1.1-1.5; p=0.0125), respectively].</p><p><strong>Conclusions: </strong>Our study confirms that only a small proportion of PCD children progress to CD. It also highlights that advancing age and the presence of autoimmune disease are the main risk factors for the development of villous atrophy. A better understanding of tTG-IgA trend during follow up could help in the management of PCD children.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical chemistry and laboratory medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1515/cclm-2025-0098","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Potential coeliac disease (PCD) is defined by the presence of positive CD-specific autoantibodies with a normal/extremely mildly damaged intestinal mucosa. This study sought to examine the progression of PCD in children maintaining a gluten-containing diet and to identify risk factors associated with the onset of CD. A comparative literature review was conducted to assess the results in the context of existing evidence.

Methods: A retrospective cohort study was performed on 67 children diagnosed with PCD between January 2005 and January 2022, with a maximum follow up of 53 months. The associations between baseline clinical characteristics and the development of CD were assessed using hazard ratios (HR).

Results: Nineteen percent (19 %) (12/67, cumulative incidence) of PCD children, with a median age of 4.3 years, progressed to CD during a median follow up period of 30 months. A fluctuating trend in tissue transglutaminase IgA (tTG-IgA) levels was observed in 35.8 % (24/67) of the children, while 46.2 % (31/67) showed tTG-IgA negativization. In univariable analysis, the presence of autoimmune disease and one-year increase in age at diagnosis were significantly associated with CD progression [HR=17.7 (95%CI: 3.0-106.8; p=0.0017) and HR=1.3 (95%CI: 1.1-1.5; p=0.0125), respectively].

Conclusions: Our study confirms that only a small proportion of PCD children progress to CD. It also highlights that advancing age and the presence of autoimmune disease are the main risk factors for the development of villous atrophy. A better understanding of tTG-IgA trend during follow up could help in the management of PCD children.

儿童潜在乳糜泻:单中心研究
目的:潜在的乳糜泻(PCD)是由存在阳性的cd特异性自身抗体和正常/极轻度损伤的肠黏膜来定义的。本研究旨在检查维持含麸质饮食的儿童PCD的进展情况,并确定与CD发病相关的危险因素。在现有证据的背景下,进行了一项比较文献综述,以评估结果。方法:对2005年1月至2022年1月诊断为PCD的67例儿童进行回顾性队列研究,最长随访53个月。使用风险比(HR)评估基线临床特征与CD发展之间的关系。结果:19%(19 %)(12/67,累积发病率)的PCD儿童,中位年龄为4.3 岁,在中位随访时间为30 个月期间进展为CD。35.8% %(24/67)患儿组织转谷氨酰胺酶IgA (tTG-IgA)水平呈波动趋势,46.2% %(31/67)患儿tTG-IgA呈阴性。在单变量分析中,自身免疫性疾病的存在和诊断时年龄增加一年与CD进展显著相关[HR=17.7 (95%CI: 3.0-106.8;p=0.0017), HR=1.3 (95%CI: 1.1 ~ 1.5;分别为p = 0.0125)。结论:我们的研究证实,只有一小部分PCD儿童进展为CD。这也强调了年龄的增长和自身免疫性疾病的存在是绒毛萎缩发展的主要危险因素。在随访中更好地了解tTG-IgA趋势有助于PCD患儿的管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical chemistry and laboratory medicine
Clinical chemistry and laboratory medicine 医学-医学实验技术
CiteScore
11.30
自引率
16.20%
发文量
306
审稿时长
3 months
期刊介绍: Clinical Chemistry and Laboratory Medicine (CCLM) publishes articles on novel teaching and training methods applicable to laboratory medicine. CCLM welcomes contributions on the progress in fundamental and applied research and cutting-edge clinical laboratory medicine. It is one of the leading journals in the field, with an impact factor over 3. CCLM is issued monthly, and it is published in print and electronically. CCLM is the official journal of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and publishes regularly EFLM recommendations and news. CCLM is the official journal of the National Societies from Austria (ÖGLMKC); Belgium (RBSLM); Germany (DGKL); Hungary (MLDT); Ireland (ACBI); Italy (SIBioC); Portugal (SPML); and Slovenia (SZKK); and it is affiliated to AACB (Australia) and SFBC (France). Topics: - clinical biochemistry - clinical genomics and molecular biology - clinical haematology and coagulation - clinical immunology and autoimmunity - clinical microbiology - drug monitoring and analysis - evaluation of diagnostic biomarkers - disease-oriented topics (cardiovascular disease, cancer diagnostics, diabetes) - new reagents, instrumentation and technologies - new methodologies - reference materials and methods - reference values and decision limits - quality and safety in laboratory medicine - translational laboratory medicine - clinical metrology Follow @cclm_degruyter on Twitter!
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信